Literature DB >> 7834829

Coexpression of P2Y and P2U receptors on aortic endothelial cells. Comparison of cell localization and signaling pathways.

D Communi1, E Raspe, S Pirotton, J M Boeynaems.   

Abstract

Depending on the vascular bed considered, the actions of ATP on the endothelium are mediated by either P2Y or P2U receptors. The two types of receptors seem to coexist on bovine aortic endothelial cells, where they are both coupled to phospholipase C. In this study, we have investigated whether they are truly coexpressed on the same cells and whether their signaling pathways diverge beyond phospholipase C activation. Measurements of [Ca2+]i in single cells showed that almost all bovine aortic endothelial cells are responsive to both 2-methylthio-ATP (2MeSATP), an agonist of P2Y receptors, and UTP, an agonist of P2U receptors. UTP stimulated the release of prostacyclin from freshly isolated bovine aortic endothelial cells, even when they were exposed to cycloheximide at the time of their collection: this indicates that P2U receptors must already be expressed on endothelial cells in situ and do not appear during cell culture. The time course of inositol phosphate (InsP) accumulation and the relative proportion of Ins(1,4,5)P3, Ins(1,3,4,5)P4, and Ins(1,3,4)P3 were similar in cells stimulated by 2MeSATP or UTP. UTP and 2MeSATP both stimulated the hydrolysis of phosphatidylcholine by phospholipase D, as reflected by the release of [3H]choline from prelabeled cells. The responses to both agents were blocked after downregulation of protein kinase C, resulting from a prolonged exposure to phorbol 12-myristate 13-acetate: this blockade occurred at a step distal to phospholipase C activation. A single difference between the two pathways has been identified: the effect of 2MeSATP on InsP3 was significantly more inhibited after a short exposure to phorbol 12-myristate 13-acetate than that of UTP.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7834829     DOI: 10.1161/01.res.76.2.191

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  13 in total

1.  Expression of P2Y receptors in cell lines derived from the human lung.

Authors:  D Communi; P Paindavoine; G A Place; M Parmentier; J M Boeynaems
Journal:  Br J Pharmacol       Date:  1999-05       Impact factor: 8.739

2.  Effects of extracellular nucleotides and nucleosides on prostate carcinoma cells.

Authors:  R Janssens; J M Boeynaems
Journal:  Br J Pharmacol       Date:  2001-01       Impact factor: 8.739

3.  Co-existence of P2Y-and PPADS-insensitive P2U-purinoceptors in endothelial cells from adrenal medulla.

Authors:  J Mateo; M T Miras-Portugal; E Castro
Journal:  Br J Pharmacol       Date:  1996-11       Impact factor: 8.739

4.  Mechanisms of agonist-dependent and -independent desensitization of a recombinant P2Y2 nucleotide receptor.

Authors:  M Otero; R C Garrad; B Velázquez; M G Hernández-Pérez; J M Camden; L Erb; L L Clarke; J T Turner; G A Weisman; F A González
Journal:  Mol Cell Biochem       Date:  2000-02       Impact factor: 3.396

5.  Pharmacological characterization of the human P2Y11 receptor.

Authors:  D Communi; B Robaye; J M Boeynaems
Journal:  Br J Pharmacol       Date:  1999-11       Impact factor: 8.739

6.  Modulation of endothelial cell migration by extracellular nucleotides: involvement of focal adhesion kinase and phosphatidylinositol 3-kinase-mediated pathways.

Authors:  Elzbieta Kaczmarek; Laurie Erb; Katarzyna Koziak; Robert Jarzyna; Marcia R Wink; Olaf Guckelberger; J Krzysztof Blusztajn; Vickery Trinkaus-Randall; Gary A Weisman; Simon C Robson
Journal:  Thromb Haemost       Date:  2005-04       Impact factor: 5.249

7.  Human P2Y2 receptor polymorphism: identification and pharmacological characterization of two allelic variants.

Authors:  R Janssens; P Paindavoine; M Parmentier; J M Boeynaems
Journal:  Br J Pharmacol       Date:  1999-06       Impact factor: 8.739

8.  Differential regulation of P2Y(11) receptor-mediated signalling to phospholipase C and adenylyl cyclase by protein kinase C in HL-60 promyelocytes.

Authors:  B C Suh; T D Kim; I S Lee; K T Kim
Journal:  Br J Pharmacol       Date:  2000-10       Impact factor: 8.739

9.  Decreased arterial PO2, not O2 content, increases blood flow through intrapulmonary arteriovenous anastomoses at rest.

Authors:  Joseph W Duke; James T Davis; Benjamin J Ryan; Jonathan E Elliott; Kara M Beasley; Jerold A Hawn; William C Byrnes; Andrew T Lovering
Journal:  J Physiol       Date:  2016-06-09       Impact factor: 5.182

10.  The ecto-nucleotidase NTPDase1 differentially regulates P2Y1 and P2Y2 receptor-dependent vasorelaxation.

Authors:  Gilles Kauffenstein; Cristina Ribas Fürstenau; Pedro D'Orléans-Juste; Jean Sévigny
Journal:  Br J Pharmacol       Date:  2010-01-08       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.